
Ernesto Arturio Grano
Examiner (ID: 19022)
| Most Active Art Unit | 3735 |
| Art Unit(s) | 3728, 3788, 3735, 4147 |
| Total Applications | 1168 |
| Issued Applications | 657 |
| Pending Applications | 77 |
| Abandoned Applications | 448 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20254871
[patent_doc_number] => 12427204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein
[patent_app_type] => utility
[patent_app_number] => 18/833679
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 2251
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18833679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/833679 | Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein | Jan 26, 2023 | Issued |
Array
(
[id] => 18535904
[patent_doc_number] => 20230240990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => LIPOSOMES ENCAPSULATING ADENOSINE
[patent_app_type] => utility
[patent_app_number] => 18/159675
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159675
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159675 | LIPOSOMES ENCAPSULATING ADENOSINE | Jan 24, 2023 | Abandoned |
Array
(
[id] => 18389715
[patent_doc_number] => 20230157933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Semisolid Oral Dispersions Comprising Active Agents
[patent_app_type] => utility
[patent_app_number] => 18/100201
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100201 | Semisolid oral dispersions comprising active agents | Jan 22, 2023 | Issued |
Array
(
[id] => 20005773
[patent_doc_number] => 20250143995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION
[patent_app_type] => utility
[patent_app_number] => 18/836992
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18836992
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/836992 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION | Jan 22, 2023 | Pending |
Array
(
[id] => 18737806
[patent_doc_number] => 20230346702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/150528
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 639
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150528
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150528 | LIPID NANOPARTICLES | Jan 4, 2023 | Pending |
Array
(
[id] => 18364923
[patent_doc_number] => 20230146514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => ORAL COMPOSITIONS AND THE PREPARATION METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/150399
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150399
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150399 | Oral compositions and the preparation methods thereof | Jan 4, 2023 | Issued |
Array
(
[id] => 19784101
[patent_doc_number] => 20250057780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => NANOPARTICLES AND METHODS OF PRODUCTION FOR THE ENCAPSULATION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/723283
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -126
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18723283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/723283 | NANOPARTICLES AND METHODS OF PRODUCTION FOR THE ENCAPSULATION OF NUCLEIC ACIDS | Dec 22, 2022 | Pending |
Array
(
[id] => 18334059
[patent_doc_number] => 20230126007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => NANOPARTICLES ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/083458
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083458
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/083458 | Nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents | Dec 15, 2022 | Issued |
Array
(
[id] => 18510116
[patent_doc_number] => 20230226217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => RNA FORMULATION FOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/071705
[patent_app_country] => US
[patent_app_date] => 2022-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18071705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/071705 | RNA FORMULATION FOR IMMUNOTHERAPY | Nov 29, 2022 | Pending |
Array
(
[id] => 18297668
[patent_doc_number] => 20230107354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => In Vivo Targeting of Extracellular Vesicles
[patent_app_type] => utility
[patent_app_number] => 17/992209
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992209 | In Vivo Targeting of Extracellular Vesicles | Nov 21, 2022 | Pending |
Array
(
[id] => 18434273
[patent_doc_number] => 20230181567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Liposomes Useful for Drug Delivery
[patent_app_type] => utility
[patent_app_number] => 17/988857
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/988857 | Liposomes Useful for Drug Delivery | Nov 16, 2022 | Abandoned |
Array
(
[id] => 19096276
[patent_doc_number] => 20240115503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 18/011635
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011635
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011635 | INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES | Nov 10, 2022 | Pending |
Array
(
[id] => 18610726
[patent_doc_number] => 20230277456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => LEVERAGING LIPID-PROTEIN INTERACTIONS TO ENGINEER SPATIAL ORGANIZATION IN CELL-FREE SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/054131
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054131
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054131 | Leveraging lipid-protein interactions to engineer spatial organization in cell-free systems | Nov 8, 2022 | Issued |
Array
(
[id] => 19628908
[patent_doc_number] => 20240407357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => Microencapsulation
[patent_app_type] => utility
[patent_app_number] => 18/699670
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18699670
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/699670 | Microencapsulation | Oct 9, 2022 | Pending |
Array
(
[id] => 18326044
[patent_doc_number] => 20230124172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/959983
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959983 | PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION | Oct 3, 2022 | Abandoned |
Array
(
[id] => 18140689
[patent_doc_number] => 20230014529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => EXOSOME SYSTEMS, PRODUCTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/952593
[patent_app_country] => US
[patent_app_date] => 2022-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17952593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/952593 | EXOSOME SYSTEMS, PRODUCTS AND METHODS | Sep 25, 2022 | Abandoned |
Array
(
[id] => 18886434
[patent_doc_number] => 11865190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto
[patent_app_type] => utility
[patent_app_number] => 17/941669
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 10741
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941669 | Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto | Sep 8, 2022 | Issued |
Array
(
[id] => 18299248
[patent_doc_number] => 20230108934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Stabilizing Camptothecin Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 17/899933
[patent_app_country] => US
[patent_app_date] => 2022-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899933
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/899933 | Stabilizing Camptothecin Pharmaceutical Compositions | Aug 30, 2022 | Abandoned |
Array
(
[id] => 19690413
[patent_doc_number] => 20250008958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => BROAD SPECTRUM ANTI-MICROBIAL POLYMERIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/684335
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18684335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/684335 | BROAD SPECTRUM ANTI-MICROBIAL POLYMERIC COMPOSITION | Aug 16, 2022 | Pending |
Array
(
[id] => 18482824
[patent_doc_number] => 20230210109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => COMPOSITIONS FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 17/886590
[patent_app_country] => US
[patent_app_date] => 2022-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/886590 | COMPOSITIONS FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS AND METHODS OF MAKING SAME | Aug 11, 2022 | Abandoned |